XML 26 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 31,701 $ 35,967
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 15,500 3,696
Depreciation, amortization and accretion, net 8,795 8,189
Change in cash surrender value of bank owned life insurance (1,293) (1,316)
Stock-based compensation expense 604 381
Operating lease payments (2,092) (2,019)
Gains on investment securities, net (913) (323)
(Gain) loss on sales of repossessed assets, net (427) 86
Loss on sale of premises and equipment 0 7
Gain on sale of other assets (26) 0
Gains on sale of loans held for sale, net (3,484) (978)
Increase in accrued interest receivable (4,651) (868)
(Decrease) increase in accrued interest payable (237) 1,117
Origination of loans held for sale (144,814) (68,022)
Proceeds from sale of loans held for sale 145,716 65,905
Increase in other investment (101) 0
(Increase) decrease in other assets (5,735) 1,230
Decrease in other liabilities (5,479) (896)
Net cash provided by operating activities 33,064 42,156
Cash flows from investing activities:    
Proceeds from maturities of certificates of deposit investments 2,910 2,209
Purchases of certificates of deposit investments (980) 0
Proceeds from sales of securities available-for-sale 3,417 20,052
Proceeds from maturities of securities available-for-sale 292,091 89,643
Proceeds from maturities of securities held-to-maturity 15,000 0
Purchases of securities available-for-sale (291,282) (132,424)
Net (increase) decrease in loans (539,867) 18,277
Purchases of premises and equipment (2,688) (3,313)
Proceeds from sales of other real property owned 1,777 700
Net cash used in investing activities (519,622) (4,856)
Cash flows from financing activities:    
Net increase in deposits 702,470 239
Decrease in federal funds purchased (5,000) 0
Decrease in repurchase agreements (37,764) (17,800)
Proceeds from FHLB advances 19,000 0
Repayment of FHLB advances (39,000) (39,000)
Proceeds from short-term debt 5,000 0
Repayment of short-term debt (5,000) 0
Repayment of long-term debt 0 (7,724)
Proceeds from issuance of common stock 473 470
Purchase of treasury stock 0 (1,129)
Dividends paid on common stock (6,316) (5,527)
Net cash provided by (used in) financing activities 633,863 (70,471)
Increase (decrease) in cash and cash equivalents 147,305 (33,171)
Cash and cash equivalents at beginning of period 85,080 141,400
Cash and cash equivalents at end of period 232,385 108,229
Cash paid during the period for:    
Interest 13,022 17,636
Income taxes 18,624 11,541
Supplemental disclosures of noncash investing and financing activities    
Loans transferred to other real estate 214 2,635
Initial recognition of right-of-use assets 0 14,116
Initial recognition of lease liabilities 0 14,116
Dividends reinvested in common stock 336 473
Net tax benefit related to option and deferred compensation plans $ 22 $ 56